Literature DB >> 8095270

Lymphocyte phenotype and function in the chronic fatigue syndrome.

S E Straus1, S Fritz, J K Dale, B Gould, W Strober.   

Abstract

Lymphocytes of 18 patients meeting the Centers for Disease Control (CDC) case definition for the chronic fatigue syndrome (CFS), 10 similar, chronically fatigued patients not fully conforming to the CDC case definition, and 17 matched, healthy individuals were studied to determine the presence of abnormalities of peripheral cell phenotype and function. Extensive phenotypic analyses of B- and T-cell subsets, natural killer (NK) cells, and macrophages were performed using single-, dual-, and three-color flow cytometry. Compared to controls, in CFS patients the percentage of CD4 T cells and CD4,CD45RA, or naive T cells, was reduced. The CD4,CD45RO, or memory T-cell, subset was numerically normal but expressed increased levels of adhesion markers (CD29, CD54, and CD58). CFS patient lymphocytes showed reduced proliferative responses to phytohemagglutinin, concanavalin A, and staphylococcal enterotoxin B. Lymphocytes from fatigue patients not meeting the CDC definition showed similar abnormalities. These data indicate that peripheral T cells manifest an increased state of differentiation in CFS and related conditions. This may arise as a consequence of an underlying neuropsychiatric and/or neuroendocrine disorder or because of exposure to antigens or superantigens of an infectious agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095270     DOI: 10.1007/bf00920633

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  52 in total

1.  History of chronic fatigue syndrome.

Authors:  S E Straus
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Circulating lymphokine levels in the chronic fatigue syndrome.

Authors:  S E Straus; J K Dale; J B Peter; C A Dinarello
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

3.  The chronic fatigue syndrome--one entity or many?

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

4.  Immune function in chronic active Epstein-Barr virus infection.

Authors:  R Kibler; D O Lucas; M J Hicks; B T Poulos; J F Jones
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

5.  The chronic fatigue syndrome.

Authors:  A L Komaroff; S E Straus; N M Gantz; J F Jones
Journal:  Ann Intern Med       Date:  1989-03-01       Impact factor: 25.391

Review 6.  Postviral fatigue syndrome.

Authors:  P O Behan; W M Behan
Journal:  Crit Rev Neurobiol       Date:  1988

7.  Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.

Authors:  S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

8.  Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome.

Authors:  C C Chao; E N Janoff; S X Hu; K Thomas; M Gallagher; M Tsang; P K Peterson
Journal:  Cytokine       Date:  1991-07       Impact factor: 3.861

9.  Human lymphocyte differentiation antigens HB-10 and HB-11. II. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations.

Authors:  T F Tedder; M D Cooper; L T Clement
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  18 in total

1.  Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion.

Authors:  J J LaManca; S A Sisto; X D Zhou; J E Ottenweller; S Cook; A Peckerman; Q Zhang; T N Denny; W C Gause; B H Natelson
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 2.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers.

Authors:  S J Hanson; W Gause; B Natelson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  A formal analysis of cytokine networks in chronic fatigue syndrome.

Authors:  Gordon Broderick; Jim Fuite; Andrea Kreitz; Suzanne D Vernon; Nancy Klimas; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2010-05-04       Impact factor: 7.217

6.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 7.  Use of exercise for treatment of chronic fatigue syndrome.

Authors:  K K McCully; S A Sisto; B H Natelson
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

8.  Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome.

Authors:  S A Sisto; W Tapp; S Drastal; M Bergen; I DeMasi; D Cordero; B Natelson
Journal:  Clin Auton Res       Date:  1995-06       Impact factor: 4.435

9.  The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome.

Authors:  D M See; P Cimoch; S Chou; J Chang; J Tilles
Journal:  Integr Physiol Behav Sci       Date:  1998 Jul-Sep

10.  Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.

Authors:  Q Zhang; X D Zhou; T Denny; J E Ottenweller; G Lange; J J LaManca; M H Lavietes; C Pollet; W C Gause; B H Natelson
Journal:  Clin Diagn Lab Immunol       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.